Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Novo Nordisk A/S - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
NVO
New York
2830
www.novonordisk.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Novo Nordisk A/S
Sector Update: Health Care Stocks Retreat Late Afternoon
- Feb 12th, 2025 8:53 pm
Novo Nordisk initiated by Morgan Stanley on equal weight coverage
- Feb 12th, 2025 4:01 pm
Why the 'best hedge' against the AI rally losing steam in 2025 is healthcare: Morning Brief
- Feb 12th, 2025 11:00 am
Novo Nordisk A/S (NVO): Among the Best International Dividend Stocks to Buy Now
- Feb 12th, 2025 5:51 am
Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today
- Feb 11th, 2025 12:13 am
Is It Worth Investing in Novo Nordisk (NVO) Based on Wall Street's Bullish Views?
- Feb 10th, 2025 2:30 pm
Hims Super Bowl Ad Spotlights Weight-Loss Drug Copycats as Clock Ticks on Their Business
- Feb 10th, 2025 12:00 pm
Novo Nordisk A/S (NVO): Among Ken Fisher’s Top High Growth Stock Picks
- Feb 8th, 2025 6:36 pm
IBD 50 Stock Hims & Hers Faces Backlash Over Provocative Super Bowl Ad
- Feb 7th, 2025 9:42 pm
Novo Nordisk’s haemophilia A drug stops bleeds in 74% of children
- Feb 7th, 2025 5:37 pm
Pharma Stock Roundup: PFE, LLY, NVO, LLY and AZN's Q4 Earnings Update
- Feb 7th, 2025 1:41 pm
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
- Feb 7th, 2025 12:54 pm
Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma news roundup
- Feb 7th, 2025 10:00 am
Novo Nordisk A/S: Once-weekly Mim8 is well-tolerated and efficacious in children living with haemophilia A with and without inhibitors
- Feb 7th, 2025 7:45 am
Denmark Could Ban Or Push Ozempic, Wegovy And Shipping Prices Through The Roof If Trump Escalates Over Greenland
- Feb 7th, 2025 3:32 am
Viking Therapeutics Plunged 6% On Its Earnings Report. Here's Why.
- Feb 6th, 2025 9:02 pm
Novo Nordisk plans new study for CagriSema, targets 2026 submission
- Feb 6th, 2025 8:41 pm
Zepbound sales keep soaring, even as weight loss drug growth slows
- Feb 6th, 2025 3:58 pm
LLY's Q4 Earnings Beat, Mounjaro, Zepbound Sales Fall Shy of Estimates
- Feb 6th, 2025 3:47 pm
Eli Lilly Adjusted Profit Tops Estimates as Weight-Loss Drug Sales Fall Short
- Feb 6th, 2025 12:11 pm
Scroll